NCT00006391: Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer |
|
|
| Completed | 1 | | US | oxaliplatin, topotecan hydrochloride | NYU Langone Health, National Cancer Institute (NCI) | Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | 11/04 | | | |
